通过监管行动提高处方药可及性 - Suppr

Improving Prescription Drug Affordability Through Regulatory Action.

作者信息

Bush Laina, Sommers Benjamin D

机构信息

Office of the Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services, Washington, DC.

出版信息

JAMA Health Forum. 2022 Aug 5;3(8):e223180. doi: 10.1001/jamahealthforum.2022.3180.

DOI:10.1001/jamahealthforum.2022.3180

PMID:36218982

Abstract

摘要

相似文献

Improving Prescription Drug Affordability Through Regulatory Action.

JAMA Health Forum. 2022 Aug 5;3(8):e223180. doi: 10.1001/jamahealthforum.2022.3180.

Barriers to Ensuring Access to Affordable Prescription Drugs.

Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:275-289. doi: 10.1146/annurev-pharmtox-010919-023518. Epub 2019 May 28.

An evaluation of rational prescribing in hospital outpatient practice in Sierra Leone and assessment of affordability of a prescription as an outcome.

Pan Afr Med J. 2018 Nov 13;31:174. doi: 10.11604/pamj.2018.31.174.16729. eCollection 2018.

Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

BMJ. 2020 Oct 8;371:m3841. doi: 10.1136/bmj.m3841.

Appropriateness and affordability of prescriptions to diabetic patients attending a tertiary hospital in Eastern Uganda: A retrospective cross-sectional study.

PLoS One. 2021 Jan 5;16(1):e0245036. doi: 10.1371/journal.pone.0245036. eCollection 2021.

Authorized Generics and Their Evolving Role in Prescription Drug Pricing and Access.

JAMA Intern Med. 2021 Apr 1;181(4):423-424. doi: 10.1001/jamainternmed.2020.8450.

Prescription drug accessibility and affordability in the United States and abroad.

Issue Brief (Commonw Fund). 2010 Jun;89:1-12.

Prescription drug prices in the US.

Med Lett Drugs Ther. 2017 May 22;59(1521):81-83.

Fair global drug pricing.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28.

Prescription Drug Priorities under the Biden Administration.

J Health Polit Policy Law. 2021 Aug 1;46(4):599-609. doi: 10.1215/03616878-8970810.

引用本文的文献

An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022.

Health Aff Sch. 2025 Mar 13;3(4):qxaf051. doi: 10.1093/haschl/qxaf051. eCollection 2025 Apr.

Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period.

J Manag Care Spec Pharm. 2024 Dec;30(12):1355-1363. doi: 10.18553/jmcp.2024.30.12.1355.

On the motivation for pharmaceutical manufacturer coupons: Brand loyalty or customer acquisition?

Health Serv Res. 2025 Apr;60(2):e14379. doi: 10.1111/1475-6773.14379. Epub 2024 Sep 1.

Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition.

JAMA Health Forum. 2024 Mar 1;5(3):e235429. doi: 10.1001/jamahealthforum.2023.5429.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Improving Prescription Drug Affordability Through Regulatory Action.

JAMA Health Forum. 2022 Aug 5;3(8):e223180. doi: 10.1001/jamahealthforum.2022.3180.

Barriers to Ensuring Access to Affordable Prescription Drugs.

Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:275-289. doi: 10.1146/annurev-pharmtox-010919-023518. Epub 2019 May 28.

An evaluation of rational prescribing in hospital outpatient practice in Sierra Leone and assessment of affordability of a prescription as an outcome.

Pan Afr Med J. 2018 Nov 13;31:174. doi: 10.11604/pamj.2018.31.174.16729. eCollection 2018.

Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

BMJ. 2020 Oct 8;371:m3841. doi: 10.1136/bmj.m3841.

Appropriateness and affordability of prescriptions to diabetic patients attending a tertiary hospital in Eastern Uganda: A retrospective cross-sectional study.

PLoS One. 2021 Jan 5;16(1):e0245036. doi: 10.1371/journal.pone.0245036. eCollection 2021.

Authorized Generics and Their Evolving Role in Prescription Drug Pricing and Access.

JAMA Intern Med. 2021 Apr 1;181(4):423-424. doi: 10.1001/jamainternmed.2020.8450.

Prescription drug accessibility and affordability in the United States and abroad.

Issue Brief (Commonw Fund). 2010 Jun;89:1-12.

Prescription drug prices in the US.

Med Lett Drugs Ther. 2017 May 22;59(1521):81-83.

Fair global drug pricing.

Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):581-583. doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28.

Prescription Drug Priorities under the Biden Administration.

J Health Polit Policy Law. 2021 Aug 1;46(4):599-609. doi: 10.1215/03616878-8970810.

引用本文的文献

An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022.

Health Aff Sch. 2025 Mar 13;3(4):qxaf051. doi: 10.1093/haschl/qxaf051. eCollection 2025 Apr.

Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period.

J Manag Care Spec Pharm. 2024 Dec;30(12):1355-1363. doi: 10.18553/jmcp.2024.30.12.1355.

On the motivation for pharmaceutical manufacturer coupons: Brand loyalty or customer acquisition?

Health Serv Res. 2025 Apr;60(2):e14379. doi: 10.1111/1475-6773.14379. Epub 2024 Sep 1.

Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition.

JAMA Health Forum. 2024 Mar 1;5(3):e235429. doi: 10.1001/jamahealthforum.2023.5429.

Improving Prescription Drug Affordability Through Regulatory Action.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Improving Prescription Drug Affordability Through Regulatory Action.

作者信息

机构信息

出版信息

相似文献

引用本文的文献